274 related articles for article (PubMed ID: 28428344)
1. Vascular adhesion protein-1 is elevated in primary sclerosing cholangitis, is predictive of clinical outcome and facilitates recruitment of gut-tropic lymphocytes to liver in a substrate-dependent manner.
Trivedi PJ; Tickle J; Vesterhus MN; Eddowes PJ; Bruns T; Vainio J; Parker R; Smith D; Liaskou E; Thorbjørnsen LW; Hirschfield GM; Auvinen K; Hubscher SG; Salmi M; Adams DH; Weston CJ
Gut; 2018 Jun; 67(6):1135-1145. PubMed ID: 28428344
[TBL] [Abstract][Full Text] [Related]
2. Regulation of mucosal addressin cell adhesion molecule 1 expression in human and mice by vascular adhesion protein 1 amine oxidase activity.
Liaskou E; Karikoski M; Reynolds GM; Lalor PF; Weston CJ; Pullen N; Salmi M; Jalkanen S; Adams DH
Hepatology; 2011 Feb; 53(2):661-72. PubMed ID: 21225644
[TBL] [Abstract][Full Text] [Related]
3. Aberrant hepatic trafficking of gut-derived T cells is not specific to primary sclerosing cholangitis.
Graham JJ; Mukherjee S; Yuksel M; Sanabria Mateos R; Si T; Huang Z; Huang X; Abu Arqoub H; Patel V; McPhail M; Zen Y; Heaton N; Longhi MS; Heneghan MA; Liberal R; Vergani D; Mieli-Vergani G; Ma Y; Hayee B
Hepatology; 2022 Mar; 75(3):518-530. PubMed ID: 34633679
[TBL] [Abstract][Full Text] [Related]
4. Gut barrier failure biomarkers are associated with poor disease outcome in patients with primary sclerosing cholangitis.
Tornai T; Palyu E; Vitalis Z; Tornai I; Tornai D; Antal-Szalmas P; Norman GL; Shums Z; Veres G; Dezsofi A; Par G; Par A; Orosz P; Szalay F; Lakatos PL; Papp M
World J Gastroenterol; 2017 Aug; 23(29):5412-5421. PubMed ID: 28839442
[TBL] [Abstract][Full Text] [Related]
5. Gut and liver T-cells of common clonal origin in primary sclerosing cholangitis-inflammatory bowel disease.
Henriksen EK; Jørgensen KK; Kaveh F; Holm K; Hamm D; Olweus J; Melum E; Chung BK; Eide TJ; Lundin KE; Boberg KM; Karlsen TH; Hirschfield GM; Liaskou E
J Hepatol; 2017 Jan; 66(1):116-122. PubMed ID: 27647428
[TBL] [Abstract][Full Text] [Related]
6. MAdCAM-1 expressed in chronic inflammatory liver disease supports mucosal lymphocyte adhesion to hepatic endothelium (MAdCAM-1 in chronic inflammatory liver disease).
Grant AJ; Lalor PF; Hübscher SG; Briskin M; Adams DH
Hepatology; 2001 May; 33(5):1065-72. PubMed ID: 11343233
[TBL] [Abstract][Full Text] [Related]
7. Circulating form of human vascular adhesion protein-1 (VAP-1): increased serum levels in inflammatory liver diseases.
Kurkijärvi R; Adams DH; Leino R; Möttönen T; Jalkanen S; Salmi M
J Immunol; 1998 Aug; 161(3):1549-57. PubMed ID: 9686623
[TBL] [Abstract][Full Text] [Related]
8. Activation of vascular adhesion protein-1 on liver endothelium results in an NF-kappaB-dependent increase in lymphocyte adhesion.
Lalor PF; Sun PJ; Weston CJ; Martin-Santos A; Wakelam MJ; Adams DH
Hepatology; 2007 Feb; 45(2):465-74. PubMed ID: 17256751
[TBL] [Abstract][Full Text] [Related]
9. Characterization of gut-homing molecules in non-endstage livers of patients with primary sclerosing cholangitis and inflammatory bowel disease.
de Krijger M; Visseren T; Wildenberg ME; Hooijer GKJ; Verstegen MMA; van der Laan LJW; de Jonge WJ; Verheij J; Ponsioen CY
J Transl Autoimmun; 2020; 3():100054. PubMed ID: 32743534
[TBL] [Abstract][Full Text] [Related]
10. Interferon-γ-dependent immune responses contribute to the pathogenesis of sclerosing cholangitis in mice.
Ravichandran G; Neumann K; Berkhout LK; Weidemann S; Langeneckert AE; Schwinge D; Poch T; Huber S; Schiller B; Hess LU; Ziegler AE; Oldhafer KJ; Barikbin R; Schramm C; Altfeld M; Tiegs G
J Hepatol; 2019 Oct; 71(4):773-782. PubMed ID: 31173810
[TBL] [Abstract][Full Text] [Related]
11. Vascular adhesion protein-1 mediates adhesion and transmigration of lymphocytes on human hepatic endothelial cells.
Lalor PF; Edwards S; McNab G; Salmi M; Jalkanen S; Adams DH
J Immunol; 2002 Jul; 169(2):983-92. PubMed ID: 12097405
[TBL] [Abstract][Full Text] [Related]
12. Gut homing receptors on CD8 T cells are retinoic acid dependent and not maintained by liver dendritic or stellate cells.
Eksteen B; Mora JR; Haughton EL; Henderson NC; Lee-Turner L; Villablanca EJ; Curbishley SM; Aspinall AI; von Andrian UH; Adams DH
Gastroenterology; 2009 Jul; 137(1):320-9. PubMed ID: 19233184
[TBL] [Abstract][Full Text] [Related]
13. Phenotyping and auto-antibody production by liver-infiltrating B cells in primary sclerosing cholangitis and primary biliary cholangitis.
Chung BK; Guevel BT; Reynolds GM; Gupta Udatha DB; Henriksen EK; Stamataki Z; Hirschfield GM; Karlsen TH; Liaskou E
J Autoimmun; 2017 Feb; 77():45-54. PubMed ID: 27784538
[TBL] [Abstract][Full Text] [Related]
14. Hepatic endothelial CCL25 mediates the recruitment of CCR9+ gut-homing lymphocytes to the liver in primary sclerosing cholangitis.
Eksteen B; Grant AJ; Miles A; Curbishley SM; Lalor PF; Hübscher SG; Briskin M; Salmon M; Adams DH
J Exp Med; 2004 Dec; 200(11):1511-7. PubMed ID: 15557349
[TBL] [Abstract][Full Text] [Related]
15. Association of HMGB1 with oxidative stress markers and regulators in PDR.
Abu El-Asrar AM; Alam K; Garcia-Ramirez M; Ahmad A; Siddiquei MM; Mohammad G; Mousa A; De Hertogh G; Opdenakker G; Simó R
Mol Vis; 2017; 23():853-871. PubMed ID: 29259392
[TBL] [Abstract][Full Text] [Related]
16. Serological biomarkers for management of primary sclerosing cholangitis.
Tornai D; Ven PL; Lakatos PL; Papp M
World J Gastroenterol; 2022 Jun; 28(21):2291-2301. PubMed ID: 35800183
[TBL] [Abstract][Full Text] [Related]
17. Targeting the Gut Microbiome as a Treatment for Primary Sclerosing Cholangitis: A Conceptional Framework.
Shah A; Macdonald GA; Morrison M; Holtmann G
Am J Gastroenterol; 2020 Jun; 115(6):814-822. PubMed ID: 32250997
[TBL] [Abstract][Full Text] [Related]
18. Phenotypic and functional characteristics of colonic lymphocytes isolated from patients with primary sclerosing cholangitis and inflammatory bowel disease.
Silvain C; Zeevi A; Saidman S; Duquesnoy RJ; Van Thiel DH
Hepatogastroenterology; 1995 Jul; 42(3):250-8. PubMed ID: 7590574
[TBL] [Abstract][Full Text] [Related]
19. Mucosal immunity in liver autoimmunity: a comprehensive review.
Trivedi PJ; Adams DH
J Autoimmun; 2013 Oct; 46():97-111. PubMed ID: 23891169
[TBL] [Abstract][Full Text] [Related]
20. Hepatic expression of secondary lymphoid chemokine (CCL21) promotes the development of portal-associated lymphoid tissue in chronic inflammatory liver disease.
Grant AJ; Goddard S; Ahmed-Choudhury J; Reynolds G; Jackson DG; Briskin M; Wu L; Hübscher SG; Adams DH
Am J Pathol; 2002 Apr; 160(4):1445-55. PubMed ID: 11943728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
